Inhibition of the transforming activity of FLT3 internal tandem duplication mutants from AML patients by a tyrosine kinase inhibitor

K. F. Tse, J. Allebach, M. Levis, B. D. Smith, F. D. Bohmer, D. Small

Research output: Contribution to journalArticlepeer-review

92 Scopus citations

Fingerprint

Dive into the research topics of 'Inhibition of the transforming activity of FLT3 internal tandem duplication mutants from AML patients by a tyrosine kinase inhibitor'. Together they form a unique fingerprint.

Medicine & Life Sciences